Vaccine

MicronJet™ Continues Its Journey to Become the Gold Standard in Intradermal Delivery

NanoPass Technologies expands global reach with four new distribution agreements across Singapore, Mexico, Colombia, and Australia, reinforcing its leadership in…

3 weeks ago

Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

One Oral Late Breaking Communication and Two Poster PresentationsNEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp.…

3 weeks ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their…

3 weeks ago

Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate

Antibody levels remained well above baseline across all six serotypes and age groups sixth month after third yearly booster doseNo…

3 weeks ago

CureVac Announces Voting Results of Extraordinary General Meeting

TÜBINGEN, DE AND BOSTON, MA / ACCESS Newswire / November 25, 2025 / CureVac N.V. (Nasdaq:CVAC)(CureVac or the Company), a…

3 weeks ago

Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology

Research & Development Council of New Jersey honors Avantor for developing a biodegradable detergent solution that advances safe, sustainable biomanufacturingRADNOR,…

3 weeks ago

BriaCell to Highlight Positive Phase 2 & Phase 3 Clinical Data at SABCS® 2025

Three poster presentations at the San Antonio Breast Cancer Symposium (December 10, 2025) will highlight positive Phase 2 safety and…

3 weeks ago

Biochips Market worth $21.36 billion by 2030 with 8.8% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Nov. 24, 2025 /PRNewswire/ -- The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01…

4 weeks ago

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

German Federal Cartel Office clearance obtained for the planned BioNTech - CureVac transaction announced on June 12, 2025, marking an…

4 weeks ago

Medicus Pharma Ltd. Explore Novel Treatment Innovations that may Revolutionize Treatments for Prostate and Skin Cancers

PHILADELPHIA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- November is Men’s Health Awareness Month, a time to spotlight the latest medical…

4 weeks ago